New research from UVA Cancer Center's Rajesh Balkrishnan, PhD, suggests that common blood pressure drugs may improve survival for patients with colorectal cancer.
New research from UVA Cancer Center’s Rajesh Balkrishnan, PhD, suggests that common blood pressure drugs may improve survival for patients with colorectal cancer.
